← Return to Deciding whether to go on abemaciclib (brand name Verzenio)

Discussion

Deciding whether to go on abemaciclib (brand name Verzenio)

Breast Cancer | Last Active: Jan 28 5:33pm | Replies (69)
Comment receiving replies
@nana2020

I have a heterogeneous tumor that contains triple negative with Ki-67 of 98% and ER+, Pr-, HER2 double equivocal with Ki-67of 90%. Original tumor was 3cm and no lymph node involvement. The chest CT at diagnosis showed some “suspicious” subpectoral nodes but not technically enlarged. I completed 11 Taxol/Carboplatin and had to stop due to low platelets. At surgery had complete pathological response and still nodes were negative. I will continue Keytruda for a year, and my oncologist is thinking about Verzenio. I am not sure I qualify for Verzenio with no node involvement and I’m terrified of having Keytruda and Verzenio at the same time. Any recommendations or suggestions?

Jump to this post

Replies to "I have a heterogeneous tumor that contains triple negative with Ki-67 of 98% and ER+, Pr-,..."
Colleen Young, Connect Director | @colleenyoung | Oct 12, 2022

@nana2020, your situation and questions sounds very similar to questions fellow members @lynelyn and @slapshotmary asked in this related discussion:
- Deciding whether to go on abemaciclib (brand name Verzenio) https://connect.mayoclinic.org/discussion/hi-and-a-question-about-abemaciclib-brand-name-verzenio/

I moved your message to the discussion so you can easily connect with Lyne and Mary as well as with @beeme @mhsosa @eku @pharmonc88 @keepmoving2 who have experience with abemaciclib (Verzenio).

Nana, what particularly concerned you about the Verzenio and Keytruda combination?

VIEW AND REPLY